Pleckstrin Homology Domain Interacting Protein (PHIP) is a member of the BRWD1-3 Family (Bromodomain and WD repeat-containing proteins). PHIP (BRWD2, WDR11) contains a WD40 repeat (methyl-lysine binder) and 2 bromodomains (acetyl-lysine binder). It was discovered through interactions with the pleckstrin homology domain of Insulin Receptor Signalling (IRS) proteins and has been shown to mediate transcriptional responses in pancreatic islet cells and postnatal growth. An initial hit for the second bromodomain of PHIP (PHIP(2)) was discovered in 2012, with consecutive research yielding a candidate with a binding anity of 68μM. PHIP (2) is an atypical category III bromodomain with a threonine (THR1396) where an asparagine residue would usually be. In the standard case, this pocket holds four water molecules, but in the case of PHIP(2), there is room for one extra water molecule -also known as PHIP water, able to mediate interaction between THR1396 and the typical water network at the back of the binding pocket. We present rst ever results of two κ-Opioid receptor (KOR) antagonists with distinct pharmacophores having an estimated binding anity in the nM to μM range, as well as higher binding anities for every currently discovered PHIP(2) ligand towards KOR. Finally, we also demonstrate selectivity of LY-255582 and LY-2459989 towards PHIP(2) over other bromodomains.
Introduction
Pre-administration of methadone was shown to enhance the apoptotic eect of doxorubicin in leukemia cells with a proposed mechanism involving lowered cAMP concentrations by inhibition of adenylyl cyclase, leading to increased caspase activity.
Likewise, signicant reduction in apoptosis was demonstrated following an increase in intracellular cAMP concentration [1, 2, 3 ] -it may however be possible that an increase in cAMP would simply mean an increase in CREBBP activity, a crucial transcriptional coactivator in the expression of P-Glycoprotein (P-GP) [4] . Furthermore, this hypothesis relies on the assumption that methadone is a P-GP inhibitor by itself, while it is only shown as a substrate [5, 6, 7] , while other sources report signicant reduction of methadone eux with the specic by addition of P-GP inhibitors [8, 9, 10] . P-GP expression is directly regulated by attachment of a variety of transcriptional factors to the promoter region of the P-GP gene; examples thereof are: p53 [11] , YB-1 [12] and NF-κB [13] .
Bromodomains are acetyl-lysine (KAc) reader regions involved in the modulation of gene expression. [14] They have now for a while been attractive targets for the treatment of diseases such as inammation and cancer, bringing about the development of a range of chemical probes for the investigation of bromodomain (Brd) biology. [15] In 2010, JQ-1 and I-BET were reported as potent inhibitors of the bromo-and extra-terminal domain (BET) bromodomain, [16, 17] and later academic and industrial research has been targeting the BET bromodomains. [18, 19, 20, 21] Pleckstrin Homology Domain Interacting Protein (PHIP) is a member of the BRWD1-3 Family (Bromodomain and WD repeat-containing proteins). PHIP (BRWD2, WDR11) contains a WD40 repeat (methyl-lysine binder) and 2 bromodomains (acetyl-lysine binder). It was discovered through interactions with the pleckstrin homology domain of Insulin Receptor Signalling (IRS) proteins and has been shown to mediate transcriptional responses in pancreatic islet cells and postnatal growth.
In addition to its role in IGF-signalling, it has been identied as the gene most highly overexpressed in metastatic melanomas, compared with primary tumors [22] , activation of PHIP promotes melanoma metastasis, and can be used as a biomarker to classify a subset of primary melanomas [23] , and that elevated PHIP copy number was associated with signicantly reduced distant metastasisfree survival and disease-specic survival by Kaplan-Meier analyses and that PHIP plays an important role as a molecular marker of melanoma ulceration, metastasis and survival [24] . Furthermore, it was identied as an increased risk in breast cancer [25] and as a tumour suppressor in Group 3 medulobalstoma [26] .
An initial hit for the second bromodomain of PHIP (PHIP(2)) was discovered in 2012 (PDB 3MB3 [14] ), with consecutive research yielding a candidate with a binding anity of 68μM [27, 28] . PHIP(2) is an atypical category III bromodomain [14] with a threonine (THR1396) where an asparagine residue would usually be. In the standard case, this pocket holds four water molecules, but in the case of PHIP(2), there is room for one extra water molecule -also known as PHIP water, able to mediate interaction between THR1396 and the typical water network at the back of the binding pocket.
Seeing how insulin can induce expression of P-GP [13] , and PHIP is involved in insulin signaling, we decided to dock methadone against PHIP(2) to evaluate whether or not methadone in fact works by inhibiting interaction with KAc residues of histones by attaching to bromodomains -more specically -PHIP (2) . Upon estimating binding anity in the micromolar region for methadone against PDB 5ENB [27] using HYDE [29, 30] , a random set of opioids was chosen for screening. With more data, the search has shown a variety of κ-Opioid receptor (KOR) antagonists having good estimated binding anities against PHIP (2) . Finally, two candidates with distinct pharmacophores were selected to probe against other bromodomains to show selectivity towards PHIP(2). Additionally, it was shown that every single molecule with high reported anity towards PHIP(2) is estimated to have even higher anity towards KOR.
Results and discussion
Initial search The initial search was not very successful, yielding only two hits with nanomolar anity. Even though MCL-117 shows no H-bonds towards the target, it was decided that the selectivity of both compounds towards μ and κ in comparison to δ warranted a restriction from including δ-Opioid receptor ligands from further screening.
κ-subtype agonists With the only hits here being Since we only want to consider ligand conformations with green torsions in SeeSAR, we dismiss all but Cyclorphan and Nalfurane. Even though the results are not that astonishing (since the estimated binding anity range is not comparable with BDBM50033530), Cyclorphan has an estimated binding anity that about ten-fold that of the experimental value of FMOOA463, although with only one recognized H-bond. A potentially additional residue could form an H-bond with the nitrogen of the piperidine substructure: Tyr1350 (g 1). This is unfortunately not conrmed because it is only recognized as hydrophobic interaction. In the case of Nalfurane (g 2), even though there is a predicted H-bond with THR1396, the estimated binding anity range is in the mM region and the uncommon torsions make it unattractive for further investigation.
κ-subtype antagonists
Since no ligand bearing green torsions with better binding anity could be found over BDBM50033530, no denitive conclusion could be made and thus, the search continued on the κ-subtype antagonists instead. A ligand with much higher estimated binding anity was discovered which, like BDBM50033530, bears 3 H-bonds towards the target (g 3). Seeing how the target is to stop PHIP(2) from interacting with acetyl-lysine residues, it would make sense that, should there be any link whatsoever between PHIP(2) and KOR, antagonists would have better binding anity, explaining the better binding anity estimations. In the case of LY-2459989 (g 4) and AT-076 (g 5), there is an H-bond network with THR1396.
Docking of LY-2459989 and LY-255582 against EP300 π-interaction to hold it in place, the result is unreliable for LY-2459989. LY-255582, on the other hand, shows a solid support from both sides using H-bonds. This is unsurprising, as EP300 and PHIP(2) share the same category [14] .
Docking of LY-2459989 and LY-255582 against BRD9 The estimated anity for both ligands is about half as good as for PHIP (2) . LY-255582 is supported from both sides (notably by π-interaction from Tyr106A), although only using 2 H-bonds (rather than 3 in the case of PHIP (2)). In the case of LY-2459989, there is only one H-bond, making it very unbalanced, even though it there is π-interaction from Tyr106A. This is good, because BRD9 is not in the same category as PHIP(2) [14] .
Docking of LY-2459989 and LY-255582 against BRD1 For LY-2459989, both H-bonds and π-interaction (with Phe714B) are one-sided, providing no good scaolding support, similar to the results towards EP300. This is not the case for LY-255582: 3 H-bonds, as well as a π-interaction with Phe714B.
The binding anities are more selective towards PHIP(2) than BRPF1. This selectivity is wanted, because BRPF1 is category IV and PHIP(2) is category III. [14] 0.3 Docking of LY-2459989 and LY-255582 against CREBBP The binding anities for both are not that great in comparison to PHIP(2), even though they are in the same category of bromodomains [14] .
Docking of LY-2459989 and LY-255582 against BAZ2A In both cases, 2 H-bonds hold the molecules in place and the estimated binding anities are over 250x lower than for PHIP (2) . This selectivity is advantageous, seeing how PHIP(2) is category III, whereas BAZ2A is category V [14] .
Docking of LY-2459989 and LY-255582 against BAZ2B Besides the estimated binding anities being at least 40x weaker in comparison to PHIP(2), desolvation is the major contributor for in both cases, shown using distances between the ligands and the water molecules. In both cases, we get very disappointing results including many red coronas. This selectivity towards PHIP(2) over BAZ2B is good because PHIP (2) is category III and BAZ2B is category V. [14] Docking of published PHIP(2) hits against KOR PDB 4DJH
In order for there to be a link between KOR and PHIP(2), conrmed ligands for PHIP(2) must demonstrate good estimated binding anity towards KOR, preferrably using the same residues being used to hold KOR antagonists in place. In this case, we chose PDB 4DJH chain A, which holds JDTic in place by interaction with residues VAL134, ASP138, MET142, and ILE294. Thus, we proceeded to dock all 7 currently published ligands, displaying the ligand of reference in chain A of PDB 4DJH [38] , since that's where binding with JDTic elicits an antagonistic response. These results are indeed very interesting, overlapping the original antagonist JDTic -in every single case, the estimated average binding anity's lower bound is much lower than the experimental values for PHIP (2) . One should however note, that FMOSA1515 is predicted to not have any H-bonds towards KOR, and that an average between lower-and upper bound results in better binding towards PHIP(2) than KOR. Looking the average estimated binding anity for each ligand, they are still much greater towards KOR in comparison to PHIP (2) , except in the case of FMOSA1515 and FMOSA1544. The result for FMOSA1515 is however unreliable, since no H-bonds are predicted. ASP138A is the most occurring binding residue, followed by ILE294. In the case of XTS942, both nitrogens are predicted to form H-bonds towards ASP138A.
Conclusion and future plans
Having found at least 2 new distinct pharmacophores with high estimated binding anity towards PHIP(2) and with the exception of EP300, are weak binders at other bromodomains, which are strong binders at KOR/MOR, there could be a structure-activity relationship between two targets, in a similar way to how PHIP interacts with IRS1. In the future,
we would like to test protein-protein interaction between bromodomains and Opioid receptors, as well as conduct binding studies and X-ray crystallography on the found ligands in combination with PHIP(2). Moreover, a relationship between PHIP(2)/EP300 and KOR antagonists could also mean that antagonists for other receptors are potentially targetting other bromodomains, opening the door for much more selective GPCR antagonist drug design, reducing unwanted side-eects, and, allowing better study of antagonism. Once this was done for all molecules, each ligand was exported individually and PoseView was used with the following command:
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